5 Marijuana Penny Stocks Poised for Growth

Canada’s Liberal government has paved the way for recreational use in the near future, boosting the value of these marijuana penny stocks trading on the TSX Venture Exchange

SmallCapPower | May 26, 2016: Canadian Prime Minister Justin Trudeau has recently announced his party’s plan to legalize marijuana sometime in the next year. As a result, the medical marijuana industry has taken off in Canada, with 31 licensed producers. Companies are eager to compete for market share in an industry that could expand quickly to $5 billion annually. Today, we have identified five Marijuana Penny Stocks that could benefit from this budding growth.

Click Read Our Top 15 Penny Stocks For 2017
Win Big With Our Small Cap Picks

 

SciVacCanopy Growth Corp. (CVE:CGC) – $2.59
Pharmaceuticals

Canopy Growth Corp, formerly Tweed Marijuana Inc., is a Canada-based producer of medical marijuana. The Company, through its subsidiaries, Tweed Inc., Tweed Farms Inc. and Bedrocan Cannabis Inc. is engaged in the business of producing and selling medical marijuana in Canada. The Company offers cannabis oils to practitioners and patients.

  • Market Cap: $278.0 Million
  • Revenues (mm): 1,869,265.33

SciVacMettrum Health Corp. (CVE:MT) – $1.49
Pharmaceuticals

Mettrum Health Corp. (Mettrum), formerly Cinaport Acquisition Corp., is a Canada-based agri-pharmaceutical company. The Company, through its wholly-owned subsidiary, Mettrum Ltd., is engaged in the research, development, production and distribution of cannabis products to the Canadian market. The Company also owns a 100% interest in Oilseed Works Inc. (OWI). OWI operates under the Hempola brand and is a Health Canada licensed producer and processor of cannabis-based products.

  • Market Cap: $59.0 Million
  • Revenues (mm): 2,411,090.97

SciVacOrganiGram Holdings Inc. (CVE:OGI) – $1.21
Pharmaceuticals

OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc. is a licensed medical marijuana producer as regulated by Health Canada under the Marihuana Medical Access Regulations (MMAR) of the Government of Canada.

  • Market Cap: $68.3 Million
  • Revenues (mm): 751,183.86

SciVacAphria Inc. (CVE:APH) – $1.45
Pharmaceuticals

Aphria, Inc. is a Canada-based company, which is engaged in greenhouse growing business. The Company is a medical marijuana producer. It provides medical marijuana to help reduce muscle spasms, appetite, or symptoms of anxiety and depression. It provides medical marijuana for end-of-life care or a specific medical condition, including multiple sclerosis, spinal cord injury, spinal cord disease, severe pain, cachexia, anorexia, weight loss, cancer, human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS), arthritis and seizures from epilepsy.

  • Market Cap: $99.2 Million
  • Revenues (mm): 443,093.61

Win Big With Our Small Cap Picks

 

DISCLAIMER
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source.